Quazepam
Discover related
4 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | DrugCentral | DailyMed | ||
|---|---|---|---|---|---|
| Classification | |||||
| Class / category | — | — | — | ||
| Also known as | doral | — | — | — | |
| Safety | |||||
| Dose · Oral | |||||
| Light | 7.5–10 mg | — | — | — | |
| Common | 10–15 mg | — | — | — | |
| Strong | 15–30 mg | — | — | — | |
| Duration | |||||
| Onset | 10–30 minutes | — | — | — | |
| Total | 6–12 hours | — | — | — | |
| After-effects | 1–24 hours | — | — | — | |
| Pharmacology | |||||
| Receptor activity | — | — | GABRA1GABRB1 | — | |
| Half-life | — | The mean elimination half-lives of both quazepam and 2-oxoquazepam is approximately 39 hours. The mean elimination half-life of N-desalkyl-2-oxoquazepam is approximately 73 hours. | — | — | |
| Protein binding | — | Quazepam and both of its major metabolites are >95% protein-bound in plasma. | — | — | |
TripSit summary
Benzodiazepine derivate drug, noral is prescribed for short term treatment of insomnia, and sleep maintenance. its MOA is very similar to Ambien and Sonata and substitutes for those in animal studies.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.